Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1996-04-24
1998-06-02
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
514170, 514171, 514843, 514899, A61K 936, A61K 3156, A61K 31565, A61K 3157
Patent
active
057595771
ABSTRACT:
A compressed medicinal tablet comprising a tablet core and a sugar coating, said sugar coating containing a dose of a hormonal steroid and a steroid release rate controlling amount of microcrystalline cellulose.
REFERENCES:
patent: 4154820 (1979-05-01), Simoons
patent: 4248856 (1981-02-01), Guley et al.
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4390531 (1983-06-01), Edgren
patent: 4425339 (1984-01-01), Pitchford
patent: 4632828 (1986-12-01), Carli
patent: 4755386 (1988-07-01), Hsiao et al.
patent: 4826831 (1989-05-01), Plunkett et al.
patent: 4927816 (1990-05-01), Ester
patent: 5073374 (1991-12-01), McCarty
patent: 5108995 (1992-04-01), Casper
patent: 5208225 (1993-05-01), Boissonneault et al.
patent: 5213808 (1993-05-01), Bar-Shalom et al.
patent: 5223268 (1993-06-01), Stetsko et al.
patent: 5340589 (1994-08-01), Stetsko et al.
patent: 5354560 (1994-10-01), Lovrecich
patent: 5384130 (1995-01-01), Kamada
patent: 5449521 (1995-09-01), Lovrecich
patent: 5547948 (1996-08-01), Barcomb
CA114(18):171312e.
CA113(14):120828z.
CA113(2):12183b.
CA111(24):219315a.
CA110(24):219101g.
CA110(14):121381y.
CA111(20):180687w.
CA106(22):182638b.
Abstract of EP 173928-A.
Abstract of WO8503436-A.
CA103(8):59333j.
CA 103(8):59308e.
Abstract of US 4720387.
CA 102(12):100833s.
CA 100(24):197789b.
CA 100(12):91412h.
Abstract of US 4415546.
Abstract of US 4415547.
Abstract of US 4327076.
Abstract of US 3980766.
CA85(20):149150m.
Abstract of US3437728.
Svensson et al Maturitas 18(3):229-238 Mar. 1994.
Gadan Revista Chilena De Obstetricia y Ginecologia 57(4):283-286 (1992).
FDC reports Pink sheet 15 Apr. 1991 Wyeth-A Yerst.sup.1, , Premarin sales set sights-premphase--A Phatic estrogen supplement, Premarin IMPA (Prempak) A Combined Estrogen--Progestin Fertility in phase (I) Regimens.
Hargrove et al Obstetrics & Gynecology 73(4):606-612 Apr. 1989.
American Home Products Corporation
Eck Steven R.
Rose Shep K.
LandOfFree
Controlled release of steroids from sugar coatings does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release of steroids from sugar coatings, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release of steroids from sugar coatings will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456819